New Drug for Opioid Agonist Treatment Added to Plan W as Limited Coverage Benefit

5/5/2020

Effective April 30, 2020, PharmaCare Plan W has added Sublocade™ (buprenorphine) to the list of Limited Coverage Drugs available to Health Benefits clients. Sublocade™ is a subcutaneous-injection, long-acting formulation of buprenorphine.

Limited Coverage Drugs, including Sublocade™, require Special Authority for coverage. Your doctor can submit a Special Authority request directly to PharmaCare.